Literature DB >> 12234158

Isotretinoin made S.M.A.R.T. and simple.

Eve J Lowenstein1.   

Abstract

With the introduction of oral isotretinoin 20 years ago, an incredible triumph was achieved in the treatment of acne vulgaris. Much has been learned of the pathogenesis of acne and the mechanism by which isotretinoin affects acne. The teratogenicity of isotretinoin has cast a shadow on this effective drug with recent concern about the regulation of its use. The S.M.A.R.T. program has been implemented to address this concern. Alleged depressive mood effects of isotretinoin have resulted in further controversy. The efficacy of and indications for isotretinoin use are discussed here, with elaboration on the reported side effects. Given its established risks, treatment with isotretinoin may become severely curtailed if caution is not exercised.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234158

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  4 in total

1.  Generic isotretinoin: a new risk for unborn children.

Authors:  Gideon Koren; Marina Avner; Neil Shear
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

Review 2.  Isotretinoin, depression and suicide: a review of the evidence.

Authors:  Parker Magin; Dimity Pond; Wayne Smith
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

3.  Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example.

Authors:  Margaret A Honein; Cynthia A Moore; J David Erickson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  An innovative approach to the topical treatment of acne.

Authors:  Adele Sparavigna; Beatrice Tenconi; Ileana De Ponti; Laura La Penna
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.